HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meletios A Dimopoulos Selected Research

Rituximab (Mabthera)

1/2022Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.
1/2022Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
11/2021Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial.
11/2018Ibrutinib and Rituximab in Waldenström's Macroglobulinemia.
6/2018Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.
1/2017BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years.
11/2015Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.
9/2015Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
11/2013Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).
1/2012Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meletios A Dimopoulos Research Topics

Disease

237Multiple Myeloma
12/2022 - 10/2003
74Neoplasms (Cancer)
11/2022 - 06/2003
43Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2022 - 05/2002
30Disease Progression
10/2022 - 07/2005
29Immunoglobulin Light-chain Amyloidosis
12/2021 - 06/2003
22Bone Diseases (Bone Disease)
03/2021 - 10/2006
20COVID-19
02/2022 - 01/2020
17Peripheral Nervous System Diseases (PNS Diseases)
10/2021 - 01/2004
17Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 12/2005
16Thrombocytopenia (Thrombopenia)
01/2022 - 04/2007
13Infections
01/2022 - 12/2008
12Neutropenia
01/2022 - 11/2010
12Amyloidosis
01/2022 - 02/2010
11Paraproteinemias (Monoclonal Gammopathy)
11/2022 - 04/2003
11Breast Neoplasms (Breast Cancer)
01/2021 - 04/2006
11Carcinoma (Carcinomatosis)
01/2015 - 06/2002
10Residual Neoplasm
01/2022 - 10/2016
10Prostatic Neoplasms (Prostate Cancer)
04/2016 - 01/2004
9Pain (Aches)
10/2021 - 02/2008
9Ovarian Epithelial Carcinoma
01/2020 - 05/2005
9Anemia
11/2018 - 12/2009
8Pneumonia (Pneumonitis)
01/2022 - 01/2016
7Monoclonal Gammopathy of Undetermined Significance
11/2022 - 04/2003
7Lymphoma (Lymphomas)
09/2021 - 04/2003
7Neoplasm Metastasis (Metastasis)
12/2020 - 09/2005
7Osteonecrosis (Kienbock's Disease)
10/2017 - 12/2005
6Plasmacytoma
06/2020 - 06/2002
6Bone Resorption
12/2019 - 03/2010
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2018 - 04/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 01/2002
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 12/2005
5Chromosome Aberrations (Chromosome Abnormalities)
01/2021 - 07/2012
5Venous Thromboembolism
01/2020 - 12/2008
5Hematologic Neoplasms (Hematological Malignancy)
04/2018 - 12/2005
5Renal Insufficiency (Renal Failure)
05/2016 - 08/2009
5Cytopenia
01/2016 - 01/2005
5Renal Cell Carcinoma (Grawitz Tumor)
02/2012 - 10/2004
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2022 - 06/2003
4Inflammation (Inflammations)
01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

105Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 01/2002
83Bortezomib (Velcade)FDA Link
01/2022 - 12/2005
70Lenalidomide (CC 5013)FDA Link
06/2022 - 03/2007
36Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 10/2003
33Proteasome InhibitorsIBA
06/2022 - 12/2005
32carfilzomibIBA
06/2022 - 01/2015
27Prednisone (Sone)FDA LinkGeneric
01/2022 - 08/2008
26daratumumabIBA
10/2022 - 10/2016
24pomalidomideIBA
01/2022 - 01/2013
24Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
21PlatinumIBA
11/2021 - 12/2004
20Immunoglobulin M (IgM)IBA
11/2022 - 04/2003
20Thalidomide (Thalomid)FDA Link
09/2019 - 10/2003
17Rituximab (Mabthera)FDA Link
01/2022 - 05/2002
17Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 06/2002
16Monoclonal AntibodiesIBA
12/2021 - 03/2009
15Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2005
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 06/2003
15Diphosphonates (Bisphosphonates)IBA
01/2020 - 12/2005
15Cisplatin (Platino)FDA LinkGeneric
01/2020 - 06/2002
11Pharmaceutical PreparationsIBA
04/2022 - 12/2007
11ixazomibIBA
01/2022 - 01/2019
11Immunomodulating AgentsIBA
01/2021 - 01/2005
10L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 03/2009
9BNT162 VaccineIBA
02/2022 - 01/2021
9Zoledronic Acid (Zometa)FDA Link
01/2021 - 12/2005
8Neutralizing AntibodiesIBA
05/2022 - 01/2021
8Carboplatin (JM8)FDA LinkGeneric
06/2016 - 01/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 01/2005
7VaccinesIBA
01/2022 - 01/2021
7CytokinesIBA
01/2022 - 06/2007
7Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2021 - 02/2010
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 01/2006
6elotuzumabIBA
06/2022 - 02/2017
6isatuximabIBA
05/2022 - 12/2019
6AntibodiesIBA
02/2022 - 06/2016
6selinexorIBA
01/2022 - 11/2020
6Amyloid (Amyloid Fibrils)IBA
01/2021 - 02/2010
6Pamidronate (Aredia)FDA LinkGeneric
10/2015 - 12/2005
5Messenger RNA (mRNA)IBA
01/2022 - 01/2013
5ibrutinibIBA
01/2022 - 06/2018
5DenosumabFDA Link
01/2021 - 05/2011
5PanobinostatIBA
01/2021 - 07/2013
5Immunoglobulins (Immunoglobulin)IBA
01/2021 - 06/2020
5Proteasome Endopeptidase Complex (Proteasome)IBA
12/2019 - 09/2010
5Angiopoietin-1IBA
10/2017 - 06/2007
5Angiopoietin-2IBA
10/2017 - 06/2007
5CreatinineIBA
04/2016 - 03/2009
5Docetaxel (Taxotere)FDA Link
10/2014 - 02/2008
5Alkaline PhosphataseIBA
01/2014 - 04/2011
5GemcitabineFDA Link
01/2010 - 07/2005
4Cell-Free Nucleic AcidsIBA
11/2022 - 12/2018
4mRNA VaccinesIBA
01/2022 - 01/2021

Therapy/Procedure

128Therapeutics
12/2022 - 12/2002
48Drug Therapy (Chemotherapy)
11/2021 - 01/2004
26Stem Cell Transplantation
06/2022 - 01/2003
13Radiotherapy
01/2021 - 01/2003
7Aftercare (After-Treatment)
01/2017 - 10/2003
7Adjuvant Chemotherapy
07/2015 - 04/2006
6Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 12/2005
4Transplantation
06/2022 - 05/2012